Hypersensitization of peripheral immune cells from major depressive disorder patients is mildly attenuated by fluoxetine in vitro

Yingqian Zhang; Qi Lai; Tangcong Chen; Yueyang Luo; M J Li; Mengqi Niu; Jing Li; Michael Maes

doi:10.1016/j.pnpbp.2026.111608

Article2025

Peripheral Immune-Inflammatory Pathways in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: Exploring Their Potential as Treatment Targets

Abbas F. Almulla, Michael Maes

Article2025

Immune cell exhaustion and apoptotic markers in major depressive disorder: Effects of in vitro cannabidiol administration

Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, Chavit Tunvirachaisakul, Atapol Sughondhabirom, Jie Li, Yingqian Zhang, Michael Maes

Preprint2024

Immune Cell Exhaustion and Apoptotic Markers in Major Depressive Disorder: Effects of in Vitro Cannabidiol Administration.

Michael Maes, Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, Chawit Tunvirachaisakul, Atapol Sughondhabirom, Yingqian Zhang, Jie Li

Article2020

Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group

Laura K. M. Han, Tim Hahn, Christopher R. K. Ching, Lisa T. Eyler, Lyubomir I. Aftanas, Moji Aghajani, André Alemán, Bernhard T. Baune, Klaus Berger, И. В. Брак, Geraldo F. Busatto, Angela Carballedo, Colm G. Connolly, Baptiste Couvy‐Duchesne, Kathryn R. Cullen, Udo Dannlowski, Christopher G. Davey, Danai Dima, Fábio Duran, Verena Enneking, Elena Filimonova, Stefan Frenzel, Thomas Frodl, Cynthia H.Y. Fu,

Preprint2019

Brain Aging in Major Depressive Disorder: Results from the ENIGMA Major Depressive Disorder working group